fig7

Screening for lipid metabolism-related genes and identifying the therapeutic potential of ACACA for ER stress-related progression in hepatocellular carcinoma

Figure 7. Drug-gene interaction network constructed using Cytoscape. Types of interaction (A), directionality of interactions (B), and (C) FDA-approved drugs targeting the core DLRGs; (D) Network showing the relationships between the 5 core DLRGs (red) and potential drugs (blue); (E) Interactions between the core gene ACACA and potential drugs, based on data from the Drug-Gene Interaction database. DLRGs: Differentially expressed lipid-related genes; FDA: Food and Drug Administration.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/